Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation

Atherosclerosis

Volumn 198, Issue 1, 2008, Pages 174-178

  Törmälä, Riina ^a   Appt, Susan ^b   Clarkson, Thomas B ^b   Groop, Per Henrik ^a,c   Rönnback, Mats ^a,c   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

Author keywords

Cardiovascular; Endothelial; Hormones; Isoflavones

Indexed keywords

AGLYCONE; EQUOL; GENISTEIN; ISOFLAVONE; PLACEBO; SOYBEAN PROTEIN; TIBOLONE;

ADULT; ARTERIAL STIFFNESS; ARTERY ENDOTHELIUM; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROVOCATION TEST; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 41049084503     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.010     Document Type: Article

References (30)

1. Clarkson T.B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 132 (2002) 566S-569S
2. Erdman J.W. Soy protein and cardiovascular disease: a statement for healthcare professionals from the nutrition committee of the AHA. Circulation 102 (2000) 2555-2559
3. Sacks F.M., Lichtenstein A., Van Horn L., et al., for American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for Professionals from the Nutrition Committee. Circulation 113 (2006) 1034-1044
4. Setchell K.D.R., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132 (2002) 3577-3584
5. Setchell K.D.R., Clerici C., Lephart E.D., et al. S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by the human bacterial flora. Am J Clin Nutr 81 (2005) 1072-1079
6. Duncan A.M., Merz-Demlow B., Xu X., Phipps W.R., and Kurzer M.S. Premenopausal equol extretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9 (2000) 581-586
7. Frankenfeld C.L., McTiernan A., Tworoger S.S., et al. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in postmenopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 88 (2004) 399-408
8. Atkinson C, Berman S, Thomas W, Lampe J. The in vitro metabolism of estrogens by human fecal bacteria: a comparison of equol-producers and non-producers. J Nutr, in press.
9. Kenemans P., Speroff L., and International Tibolone Consensus Group. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 51 (2005) 21-28
10. Eden J. The need for tissue selective menopausal agents. Gynecol Endocrinol 21 S1 (2005) 22-27
11. Speroff L., and Clarkson T.B. Is tibolone a viable alternative to HT?. Contemp Ob/Gyn (2003) 2-11
12. Bots M.L., Evans G.W., Riley W., et al. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the osteoporosis prevention and arterial effects of tibolone (OPAL) study. Eur Heart J 27 (2006) 746-755
13. Clarkson T.B. Does tibolone exacerbate atherosclerosis?. Eur Heart J 27 (2006) 635-637
14. Mahady G.B., Parrot J., Lee C., Yun G.S., and Dan A. Botanical dietary supplement use in peri- and postmenopausal women. Menopause 10 (2003) 65-72
15. Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 118 (2005) 98S-108S
16. Nikander E., Kilkkinen A., Metsä-Heikkilä M., et al. A randomized placebo-controlled cross-over trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 101 (2003) 1213-1220
17. Törmälä RM, Appt S, Clarkson TB, Tikkanen MJ, Ylikorkala O, Mikkola TS. Individual differences in equol production capability modulate blood pressure in tibolone treated postmenopausal women; lack of effect of soy supplementation. Climacteric, in press.
18. Wilkinson I.B., Hall I.R., MacCallum H., et al. Pulse-wave analysis. Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22 (2002) 147-152
19. Mackenzie I.S., Wilkinson I.B., and Cockroft J.R. Assessment of arterial stiffness in clinical practice. Q J Med 95 (2002) 67-74
20. Sarabi M., Vessby B., Millgård J., and Lind L. Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. Atherosclerosis 156 (2001) 349-355
21. Rönnback M., Hernelahti M., Hämäläinen E., Groop P.-H., and Tikkanen H. Effect of physical activity and muscle morphology on endothelial function and arterial stiffness. Scand J Med Sci Sports 1 (2006) Epub ahead of print
22. Atkinson C., Frankenfeld C.L., and Lampe J.L. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 230 (2005) 155-170
23. Erenus M., Ilhan A.H., and Elter K. Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries. Fertil Steril 79 (2003) 268-273
24. Steinberg F.M., Guthrie N.L., Villablanca A.C., Kumar K., and Murray M.J. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78 (2003) 123-130
25. Cockcroft J.R. Exploring vascular benefits of endothelium-derived nitric oxide. Am J Hypertens 18S (2005) 177-183
26. Castelo-Branco C., Garcia-Fantini M., and Haya J. Vascular reactivity and atheromatous plaques in postmenopausal women on tibolone treatment. Open prospective study with Doppler ultrasonography in internal carotid artery. Maturitas 50 (2005) 259-265
27. Somunkiran A., Yazici B., Demirci F., Erdogmus B., and Ozdemir I. Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause. Climacteric 9 (2006) 59-65
28. Colacurci N., Chiàntera A., Fornaro F., et al. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 12 (2005) 299-307
29. Hale G., Paul-Labrador M., Dwyer J.H., and Bairey Merz C.N. Isoflavone supplementation and endothelial function in menopausal women. Clin Endocrinol 56 (2002) 693-701
30. Kreijkamp-Kaspers S., Kok L., Bots M.L., et al. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 81 (2005) 189-195